JP5329969B2 - エポキシブタノール中間体の製造方法 - Google Patents

エポキシブタノール中間体の製造方法 Download PDF

Info

Publication number
JP5329969B2
JP5329969B2 JP2008542575A JP2008542575A JP5329969B2 JP 5329969 B2 JP5329969 B2 JP 5329969B2 JP 2008542575 A JP2008542575 A JP 2008542575A JP 2008542575 A JP2008542575 A JP 2008542575A JP 5329969 B2 JP5329969 B2 JP 5329969B2
Authority
JP
Japan
Prior art keywords
formula
hal
compound
fluoro
same meaning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2008542575A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009517413A (ja
JP2009517413A5 (https=
Inventor
ミュレール，マルク
シュ，リン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Basilea Pharmaceutica AG
Original Assignee
Basilea Pharmaceutica AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica AG filed Critical Basilea Pharmaceutica AG
Publication of JP2009517413A publication Critical patent/JP2009517413A/ja
Publication of JP2009517413A5 publication Critical patent/JP2009517413A5/ja
Application granted granted Critical
Publication of JP5329969B2 publication Critical patent/JP5329969B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/08—Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
JP2008542575A 2005-12-01 2006-11-29 エポキシブタノール中間体の製造方法 Expired - Fee Related JP5329969B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05026163 2005-12-01
EP05026163.5 2005-12-01
PCT/CH2006/000671 WO2007062542A2 (en) 2005-12-01 2006-11-29 Process for the manufacture of epoxybutanol intermediates

Publications (3)

Publication Number Publication Date
JP2009517413A JP2009517413A (ja) 2009-04-30
JP2009517413A5 JP2009517413A5 (https=) 2010-01-07
JP5329969B2 true JP5329969B2 (ja) 2013-10-30

Family

ID=36178579

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008542575A Expired - Fee Related JP5329969B2 (ja) 2005-12-01 2006-11-29 エポキシブタノール中間体の製造方法

Country Status (19)

Country Link
US (2) US7816537B2 (https=)
EP (2) EP1954264B1 (https=)
JP (1) JP5329969B2 (https=)
KR (1) KR101191682B1 (https=)
CN (1) CN101321522B (https=)
AT (1) ATE444747T1 (https=)
AU (2) AU2006319657B2 (https=)
BR (1) BRPI0619120B1 (https=)
CA (2) CA2711852C (https=)
CY (1) CY1110588T1 (https=)
DE (1) DE602006009698D1 (https=)
DK (1) DK1954264T3 (https=)
ES (1) ES2333258T3 (https=)
HR (1) HRP20090675T1 (https=)
PL (1) PL1954264T3 (https=)
PT (1) PT1954264E (https=)
SI (1) SI1954264T1 (https=)
WO (1) WO2007062542A2 (https=)
ZA (1) ZA200804218B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI483950B (zh) 2009-09-21 2015-05-11 Gilead Sciences Inc 用於製備１’－取代碳核苷類似物之方法及中間物
BR122020020745B8 (pt) 2010-07-22 2023-10-31 Gilead Sciences Inc Composto antiviral para o tratamento de infecções por paramyxoviridae e composição farmacêutica que o compreende
HUE031679T2 (en) 2012-08-07 2017-07-28 Basilea Pharmaceutica Ag Process for the preparation of isavuconazole or ravuconazole
WO2015150947A1 (en) 2014-03-29 2015-10-08 Wockhardt Limited A process for the preparation of isavuconazole and its intermediates
TWI767201B (zh) 2014-10-29 2022-06-11 美商基利科學股份有限公司 絲狀病毒科病毒感染之治療
SI3349758T1 (sl) 2015-09-16 2022-08-31 Gilead Sciences, Inc. Postopki za zdravljenje okužb z virusom arenaviridae
CN105367528A (zh) * 2015-11-10 2016-03-02 南通诺泰生物医药技术有限公司 一种三唑类药物中间体(d)-1-(1-环烷仲胺基)-2-(2-四氢吡喃基)氧-1-丙酮类化合物及合成方法
US10682368B2 (en) 2017-03-14 2020-06-16 Gilead Sciences, Inc. Methods of treating feline coronavirus infections
AU2018262501B2 (en) 2017-05-01 2020-12-10 Gilead Sciences, Inc. Crystalline forms of (S) 2 ethylbutyl 2 (((S) (((2R,3S,4R,5R) 5 (4 aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2 yl)methoxy)(phenoxy) phosphoryl)amino)propanoate
WO2019014247A1 (en) 2017-07-11 2019-01-17 Gilead Sciences, Inc. COMPOSITIONS COMPRISING POLYMERASE RNA INHIBITOR AND CYCLODEXTRIN FOR THE TREATMENT OF VIRAL INFECTIONS
WO2019031240A1 (ja) 2017-08-10 2019-02-14 住友化学株式会社 エポキシアルコール化合物の製造方法
US11660307B2 (en) 2020-01-27 2023-05-30 Gilead Sciences, Inc. Methods for treating SARS CoV-2 infections
JP7554841B2 (ja) 2020-03-12 2024-09-20 ギリアード サイエンシーズ， インコーポレイテッド １’－シアノヌクレオシドを調製する方法
WO2021207049A1 (en) 2020-04-06 2021-10-14 Gilead Sciences, Inc. Inhalation formulations of 1'-cyano substituted carbanucleoside analogs
CA3179226A1 (en) 2020-05-29 2021-12-02 Tomas Cihlar Remdesivir treatment methods
AU2021296841B2 (en) 2020-06-24 2025-01-23 Gilead Sciences, Inc. 1'-cyano nucleoside analogs and uses thereof
SI4204421T1 (sl) 2020-08-27 2024-07-31 Gilead Sciences, Inc., Spojine in postopki za zdravljenje virusnih okužb
IL315102A (en) 2022-03-02 2024-10-01 Gilead Sciences Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
US12357577B1 (en) 2024-02-02 2025-07-15 Gilead Sciences, Inc. Pharmaceutical formulations and uses thereof
CN115536643A (zh) * 2022-12-05 2022-12-30 南京桦冠生物技术有限公司 一种艾沙康唑类药物关键中间体的制备方法
CN119264078B (zh) * 2024-12-09 2025-08-01 浙江世佳科技股份有限公司 一种(5s,6r)-5,6-环氧-2-十七碳炔-1-醇的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3452213B2 (ja) * 1994-07-05 2003-09-29 エーザイ株式会社 抗真菌剤及びその製造方法
AU2931399A (en) 1998-03-06 1999-09-20 F. Hoffmann-La Roche Ag 3-(4-(4-cyanophenyl)thiazol-2-y))-1-(1h-1,2,4-triazol-1-yl) -butan-2-ol derivatives having antifungal activity
US6133485A (en) 1998-04-15 2000-10-17 Synphar Laboratories, Inc. Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols
US6391903B1 (en) 1999-09-09 2002-05-21 Sankyo Company, Limited Triazole derivatives having antifungal activity
US6884892B2 (en) 2002-06-20 2005-04-26 Sumitomo Chemical Company, Limited Production methods of epoxytriazole derivative and intermediate therefor
JP4627413B2 (ja) * 2003-05-06 2011-02-09 三井化学株式会社 １−アゾール−２−フェニル−２、３−プロパンジオール誘導体の製造法

Also Published As

Publication number Publication date
US20110021794A1 (en) 2011-01-27
HRP20090675T1 (hr) 2010-01-31
PT1954264E (pt) 2009-12-23
JP2009517413A (ja) 2009-04-30
US7816537B2 (en) 2010-10-19
US8076494B2 (en) 2011-12-13
SI1954264T1 (sl) 2010-01-29
EP1954264A2 (en) 2008-08-13
DE602006009698D1 (de) 2009-11-19
BRPI0619120A2 (pt) 2011-09-13
WO2007062542A2 (en) 2007-06-07
BRPI0619120B1 (pt) 2023-10-10
PL1954264T3 (pl) 2010-02-26
CA2629092C (en) 2012-01-03
CN101321522A (zh) 2008-12-10
WO2007062542A3 (en) 2007-11-01
DK1954264T3 (da) 2010-01-11
EP2133345A1 (en) 2009-12-16
CA2629092A1 (en) 2007-06-07
KR20080075014A (ko) 2008-08-13
CA2711852C (en) 2011-10-04
CY1110588T1 (el) 2015-04-29
EP1954264B1 (en) 2009-10-07
AU2010203301B2 (en) 2012-06-21
AU2006319657A1 (en) 2007-06-07
ZA200804218B (en) 2009-01-28
US20090299073A1 (en) 2009-12-03
ES2333258T3 (es) 2010-02-18
CA2711852A1 (en) 2007-06-07
CN101321522B (zh) 2012-05-30
KR101191682B1 (ko) 2012-10-16
ATE444747T1 (de) 2009-10-15
AU2006319657B2 (en) 2010-08-12
AU2010203301A1 (en) 2010-08-12

Similar Documents

Publication Publication Date Title
JP5329969B2 (ja) エポキシブタノール中間体の製造方法
JP2009517413A5 (https=)
US6809223B2 (en) Process for stereoselective synthesis of prostacyclin derivatives
JP2013532131A (ja) ポサコナゾール中間体の製造
JP4336648B2 (ja) エポキシトリアゾール誘導体およびその中間体の製造方法
JP2002511434A5 (https=)
US6133485A (en) Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols
CA2063851C (en) Method for producing ethers
JP4404611B2 (ja) エポキシトリアゾール化合物の製造方法及びその中間体
JP4330898B2 (ja) 光学活性２−フェニル−２，３−ジヒドロキシプロピルアゾール誘導体の製造法
JPH05213808A (ja) 置換化ヒドロキノン誘導体
JPH0249311B2 (https=)
JP3856241B2 (ja) １（２ｈ）−キノリンカルボン酸の新規な誘導体、その合成方法及び抗生剤作用を有する化合物を合成するためのその使用方法
JPH0465065B2 (https=)
EP0006615A1 (en) Process for preparing epihalohydrin enantiomers
JPH0130828B2 (https=)
JPH1087645A (ja) β−アミノエステルの製造法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091112

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091112

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120904

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121120

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121128

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121225

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130107

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130204

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130305

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130604

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130702

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130725

R150 Certificate of patent or registration of utility model

Ref document number: 5329969

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees